New description of an MRPS2 homozygous patient: Further features to help expend the phenotype

Thalia Papadopoulos1, Pauline Gaignard2, Manuel Schiff3

  • 1APHP.Nord, Robert-Debré University Hospital, Department of Genetics, F-75019, Paris, France.

PubMed

Insights

Mutations in mito-ribosomal protein S2 (MRPS2) are linked to rare disorders. This study identifies new symptoms including microcephaly, joint hypermobility, and autistic features in a novel patient.

Area of Science:

  • Genetics
  • Mitochondrial Biology
  • Neurodevelopmental Disorders

Background:

  • Mutations in mito-ribosomal protein S2 (MRPS2) are associated with a spectrum of rare genetic disorders.
  • Previous cases of MRPS2 mutations presented with sensorineural hearing impairment, developmental delay, hypoglycemia, lactic acidemia, and oxidative phosphorylation deficiencies.

Observation:

  • A novel homozygous MRPS2 mutation was identified in a subject with a unique clinical presentation.
  • The subject exhibited initial microcephaly, joint hypermobility, and autistic features.

Findings:

  • This case expands the known phenotypic spectrum of MRPS2-related disorders.
  • The observed features, including microcephaly, joint hypermobility, and autistic features, have not been previously reported in association with MRPS2 mutations.

Implications:

  • Understanding the full phenotypic variability of MRPS2 mutations is crucial for accurate diagnosis and genetic counseling.
  • Further research into the molecular mechanisms underlying MRPS2 function may reveal new therapeutic targets for mitochondrial and neurodevelopmental disorders.